Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: J Immigr Minor Health. 2022 Apr 12;24(6):1459–1468. doi: 10.1007/s10903-022-01356-2

Table 4:

Estimated location of HIV acquisition, African-born people with a new HIV diagnosis, 2000–2017, King County, WA, New York City, Chicago, and Philadelphia*

Definitely Africa Probably Africa Probably U.S. Definitely U.S. Inadequate information Total

All participants (N, %) 92 (51.4) 9 (5.0) 12 (6.7) 29 (16.2) 37 (20.7) 179 (100)
Percent in each category excluding those with inadequate information 64.8 6.3 8.5 20.4 --
Diagnosed in the U.S. (%) 25 (28.1) 9 (100) 12(100) 28 (100) 36 (100) 110 (63.2)
Median time in U.S. to diagnosis^ (years, range) 0.5 (0.1 –7.6) 1.4 (0.50–10.0) 6.6 (0.75–15.1) 5.0 (0.50–30.6) 3.2 (0.17–22.3) 2.6 (0.7–30.6)
Median CD4 at diagnosis* (range) 135 (13–1053) 89 (26–303) 274 (0–627) 394 (20–656) 321 (4–818) 293 (0–1053)
Concurrent HIV and AIDS diagnosi^ (%) 12 (54.6) 8 (100) 5 (45.5) 6 (25.0) 11 (40.7) 42 (45.6)
Had ≥1 negative HIV test in the U.S.^ (%) 0 (0) 0 (0) 2 (20.0) 13 (44.8) 2 (5.7) 0 (0.0)
*

While participants were newly diagnosed in the U.S. from 2000–2017, in some cases they reported positive tests outside of the U.S. prior to 2000.

^

Among those diagnosed in the U.S.